These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 440368

  • 21. The prolactinoma problem.
    Reichlin S.
    N Engl J Med; 1979 Feb 08; 300(6):313-5. PubMed ID: 759885
    [No Abstract] [Full Text] [Related]

  • 22. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
    Tindall GT, Kovacs K, Horvath E, Thorner MO.
    J Clin Endocrinol Metab; 1982 Dec 08; 55(6):1178-83. PubMed ID: 6752167
    [No Abstract] [Full Text] [Related]

  • 23. [Bromocriptine treatment of prolactinomas and primary hyperprolactinemia (author's transl)].
    Fossati P, Grenier JL, Stevenard C, Fermon C, Christiaens JL, Linquette M.
    Ann Med Interne (Paris); 1982 Dec 08; 133(1):45-7. PubMed ID: 7065588
    [Abstract] [Full Text] [Related]

  • 24. [Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
    Sato O, Niwa J, Inoue Y, Akagawa S, Kobayashi K.
    No Shinkei Geka; 1983 Jan 08; 11(1):51-60. PubMed ID: 6682184
    [No Abstract] [Full Text] [Related]

  • 25. [Significance of prolactinoma in management of anovulation].
    Kurachi K, Aono T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep 08; 34(9):1581-6. PubMed ID: 7130780
    [No Abstract] [Full Text] [Related]

  • 26. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH, Figueroa CD, Smith CM, Bhoola KD.
    Agents Actions Suppl; 1992 Sep 08; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [Abstract] [Full Text] [Related]

  • 27. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
    Nissim M, Ambrosi B, Bernasconi V, Giannattasio G, Giovanelli MA, Bassetti M, Vaccari U, Moriondo P, Spada A, Travaglini P, Faglia G.
    J Endocrinol Invest; 1982 Sep 08; 5(6):409-15. PubMed ID: 7169515
    [No Abstract] [Full Text] [Related]

  • 28. Prolactinomas: medical or surgical treatment?
    Lawton NF.
    Q J Med; 1987 Jul 08; 64(243):557-64. PubMed ID: 3313493
    [No Abstract] [Full Text] [Related]

  • 29. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM, Gancel A, Weinstein A, Courtois H, Schrub JC, Tadie M, Wolf LM.
    Presse Med; 1985 Mar 02; 14(9):525-8. PubMed ID: 3157164
    [Abstract] [Full Text] [Related]

  • 30. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM, Scanlon MF, Hall K, Cook DB, Hall R.
    N Engl J Med; 1979 Feb 08; 300(6):291-3. PubMed ID: 759882
    [No Abstract] [Full Text] [Related]

  • 31. [Bromocriptine therapy of prolactinoma in pregnancy].
    Nehmzow M, Ventz M, Meng W.
    Zentralbl Gynakol; 1985 Feb 08; 107(14):899-903. PubMed ID: 4036407
    [Abstract] [Full Text] [Related]

  • 32. Prolactin secreting adenoma in 22 men.
    Grisoli F, Vincentelli F, Jaquet P, Guibout M, Hassoun J, Farnarier P.
    Surg Neurol; 1980 Apr 08; 13(4):241-7. PubMed ID: 7376059
    [Abstract] [Full Text] [Related]

  • 33. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL, Scheithauer BW, Abboud CF, Laws ER.
    J Neurosurg; 1987 Dec 08; 67(6):816-21. PubMed ID: 3681421
    [Abstract] [Full Text] [Related]

  • 34. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N.
    Obstet Gynecol; 1987 Jan 08; 69(1):99-103. PubMed ID: 3099236
    [Abstract] [Full Text] [Related]

  • 35. CSF rhinorrhea after bromocriptine for prolactinoma.
    Baskin DS, Wilson CB.
    N Engl J Med; 1982 Jan 21; 306(3):178. PubMed ID: 7054671
    [No Abstract] [Full Text] [Related]

  • 36. Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?
    Landolt AM, Osterwalder V.
    J Clin Endocrinol Metab; 1984 Jun 21; 58(6):1179-83. PubMed ID: 6725514
    [Abstract] [Full Text] [Related]

  • 37. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G.
    Prog Clin Biol Res; 1982 Jun 21; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract] [Full Text] [Related]

  • 38. [Morphological study of a prolactin-secreting pituitary adenoma after therapy with 2-bromo-alpha-erogocryptine (CB154) (author's transl)].
    Beauvillain JC, Tramu G, Mazzuca M, Christiaens JL, L'Hermite ML, Asfour M, Fossati P, Linquette M.
    Ann Endocrinol (Paris); 1976 Jun 21; 37(2):117-8. PubMed ID: 1036873
    [Abstract] [Full Text] [Related]

  • 39. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
    Thorner MO, Martin WH, Rogol AD, Morris JL, Perryman RL, Conway BP, Howards SS, Wolfman MG, MacLeod RM.
    J Clin Endocrinol Metab; 1980 Sep 21; 51(3):438-45. PubMed ID: 6773972
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.